30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma
Main Authors: | Arnab Basu, Eddy Yang, Yash Suri, Lakshminarayan Nandagopal, Mollie Deshazo, Lyse Norian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
The Role of Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) in Appendicitis
by: Moch Junaidy Heriyanto, et al.
Published: (2023-10-01) -
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) Can Predict Spontaneous Preterm Birth?
by: Yuce E
Published: (2023-06-01) -
Are Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Predictors of Steroid Therapy in Children with Nephrotic Syndrome?
by: Mahnaz Jamee, et al.
Published: (2022-07-01) -
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE)
by: Marwa Sayed Meshaal, et al.
Published: (2019-09-01) -
Preoperative neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) as prognostic markers in patients with retroperitoneal liposarcoma
by: Dorian Yarih Garcia-Ortega, et al.
Published: (2022-06-01)